Unicycive Therapeutics, Inc. (UNCY) Operating cash flow 2020–2025
Unicycive Therapeutics, Inc. (UNCY) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$31.3MFY2025 · since FY2020: -$1.5M → -$31.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$31.3M | -9.6% |
| FY2024 | -$28.6M | -56.3% |
| FY2023 | -$18.3M | -16.8% |
| FY2022 | -$15.7M | -171.4% |
| FY2021 | -$5.8M | -295.3% |
| FY2020 | -$1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice